Just for interest ....
Spark Plus posted this ANP announcement on LinkedIn recently and the post was liked by a Study Manager from Roche Diagnostics.
It's interesting because Roche is such a large player in COVID diagnostics as well as DMD potentially (via Sarepta).
It would be nice if Roche is taking a close look at ANP's research .... could be just a coincidence though.
DYOR, not advice etc
News: ANP Antisense Therapeutics Submits Clinical Trial Application For Atl1102 Phase Iib Dmd Trial..., page-18
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
